Michael Gilbertson

1.0k total citations
31 papers, 469 citations indexed

About

Michael Gilbertson is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Michael Gilbertson has authored 31 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 7 papers in Hematology. Recurrent topics in Michael Gilbertson's work include Lymphoma Diagnosis and Treatment (21 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and Viral-associated cancers and disorders (5 papers). Michael Gilbertson is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and Viral-associated cancers and disorders (5 papers). Michael Gilbertson collaborates with scholars based in Australia, United States and United Kingdom. Michael Gilbertson's co-authors include Stephen Opat, Judith Ashley, Suzanne E. Perumean‐Chaney, Vicki Bovee, Jon P. Schrage, Sachiko T. St. Jeor, David Ritchie, John F. Seymour, Constantine S. Tam and Pasquale L. Fedele and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael Gilbertson

27 papers receiving 449 citations

Peers

Countries citing papers authored by Michael Gilbertson

Since Specialization

Citations

This map shows the geographic impact of Michael Gilbertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gilbertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gilbertson more than expected).

Fields of papers citing papers by Michael Gilbertson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gilbertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gilbertson. The network helps show where Michael Gilbertson may publish in the future.

Co-authorship network of co-authors of Michael Gilbertson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gilbertson. A scholar is included among the top collaborators of Michael Gilbertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gilbertson. Michael Gilbertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study 2025 ·Blood Advances ·Allison Barraclough, Sze Ting Lee, Melinda Burgess, Leonid Churilov, Geoffrey Chong, (unknown), Michael Gilbertson, (unknown), (unknown), David Ritchie, Rachel Koldej, Andrew M. Scott, Colm Keane, Eliza A. Hawkes	0
2	Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach 2025 ·Internal Medicine Journal ·(unknown), (unknown), (unknown), George Grigoriadis, Shaun Fleming, (unknown), Pasquale L. Fedele, Michael Löw, Paul Yeh, Michael Gilbertson, (unknown), Gareth P. Gregory, (unknown), (unknown), Zane Kaplan, Sanjeev Chunilal, S. Brown, Stephen Opat, Chong Chyn Chua, Jake Shortt	0
3	Next-generation sequencing RNA fusion panel for the diagnosis of haematological malignancies 2024 ·Pathology ·(unknown), (unknown), (unknown), (unknown), Jake Shortt, Pasquale L. Fedele, Michael Gilbertson, Chun Yew Fong, Naranie Shanmuganathan, Beena Kumar, Paul Yeh	2
4	Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance 2023 ·British Journal of Haematology ·(unknown), (unknown), Mark N. Polizzotto, Sam Milliken, Tara Cochrane, (unknown), (unknown), (unknown), Michael Gilbertson, (unknown), Chan Y. Cheah, Maya Latimer, Nada Hamad, Matthew Ku	4
5	Frontline treatment of follicular lymphoma with atezolizumab and obinutuzumab, with and without radiotherapy (The FLUORO study). 2022 ·Journal of Clinical Oncology ·Eliza A. Hawkes, (unknown), Richard Khor, (unknown), Sze Ting Lee, Denise Lee, Belinda A. Campbell, Anneke Grobler, Michael Gilbertson, Jodie Palmer, Geoff Chong	1
6	Low mortality in vaccinated immunocompromised haematology patients infected with SARS‐CoV‐2 2022 ·Internal Medicine Journal ·(unknown), Jake Shortt, Michael Löw, Benjamin A. Rogers, Zane Kaplan, Pasquale L. Fedele, Gareth P. Gregory, (unknown), Michael Gilbertson, George Grigoriadis, Stephen Opat	5
7	A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma 2021 ·Journal of Hematology ·(unknown), (unknown), Michael Gilbertson, Zoe McQuilten, Stephen Opat, Claire Dendle	1
8	Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron‐deficiency anaemia: a Phase II single‐arm study 2021 ·Internal Medicine Journal ·Sant‐Rayn Pasricha, Michael Gilbertson, (unknown), (unknown), (unknown), (unknown), Anouk Dev, Sanjeev Chunilal, Stephen Opat	2
9	Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapy 2020 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), (unknown), (unknown), Sanjeev Chunilal, Jake Shortt, (unknown), George Grigoriadis, Sushrut Patil, Gareth P. Gregory, Stephen Opat, Michael Gilbertson	10
10	Immune Priming with Single-Agent Nivolumab Followed By Combined Nivolumab & Rituximab Is Safe and Efficacious for First-Line Treatment of Follicular Lymphoma; Interim Analysis of the '1st FLOR' Study 2019 ·Blood ·Allison Barraclough, (unknown), Michael Gilbertson, Andrew Grigg, Leonid Churilov, (unknown), David Ritchie, Rachel Koldej, Rishu Agarwal, (unknown), Charmaine Smith, (unknown), (unknown), Eliza A. Hawkes	7
11	Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma 2019 ·Scientific Reports ·(unknown), Joshua Casan, Jake Shortt, Eliza A. Hawkes, Michael Gilbertson, Zoe McQuilten, George Grigoriadis, (unknown), (unknown), Philip Campbell, Khai Li Chai, Hang Quach, Sushrut Patil, Stephen Opat	5
12	Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission 2018 ·British Journal of Cancer ·Eliza A. Hawkes, (unknown), (unknown), Geoff Chong, F. Ha, Michael Gilbertson, Andrew Grigg	9
13	Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma 2017 ·Scientific Reports ·Claire Dendle, Michael Gilbertson, Tim Spelman, Rhonda L. Stuart, Tony M. Korman, Karin Thursky, Stephen Opat, Zoe McQuilten	21
14	Linezolid-associated reticulocytopenia 2016 ·Annals of Hematology ·(unknown), (unknown), Jun Kong, S. Brown, Michael Gilbertson	2
15	Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma 2016 ·Annals of Hematology ·Pasquale L. Fedele, Gareth P. Gregory, Michael Gilbertson, Jake Shortt, Beena Kumar, Stephen Opat, George Grigoriadis	15
16	Improved Survival of Older Patients with Mantle Cell Lymphoma (MCL) with Front-Line Cytarabine-Based Immunochemotherapy 2016 ·Blood ·(unknown), Michael Gilbertson, Zoe McQuilten, (unknown), George Grigoriadis, (unknown), Philip Campbell, Khai Li Chai, Hang Quach, Sushrut Patil, Jake Shortt, Stephen Opat	2
17	Disseminated Enteroviral Infection Associated with Obinutuzumab 2015 ·Emerging infectious diseases ·Claire Dendle, Michael Gilbertson, Tony M. Korman, Vera Golder, Eric F. Morand, Stephen Opat	16
18	A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma 2014 ·British Journal of Cancer ·Chan Y. Cheah, Kirsten Herbert, (unknown), Glen Kennedy, Alexander George, Pasquale L. Fedele, Michael Gilbertson, Soo‐Yong Tan, David Ritchie, Stephen Opat, H. Miles Prince, Michael Dickinson, Kate Burbury, M. Wolf, E. Januszewicz, Constantine S. Tam, David Westerman, Dennis Carney, Simon J. Harrison, John F. Seymour	89
19	Is CD20 positive plasma cell myeloma a unique clinicopathological entity? A study of 40 cases and review of the literature 2012 ·Pathology ·George Grigoriadis, Michael Gilbertson, Neil Came, (unknown), (unknown), (unknown), (unknown), Surender Juneja	14
20	Weight Control in the Physician's Office 2001 ·Archives of Internal Medicine ·Judith Ashley, Sachiko T. St. Jeor, Jon P. Schrage, Suzanne E. Perumean‐Chaney, Michael Gilbertson, (unknown), Vicki Bovee	132

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact